BIOMAT Database Logo BIOMAT Database Logo

Synergistic inhibition of HIV-1 reverse transcriptase DNA polymerase activity and virus replication in vitro by combinations of carboxanilide nonnucleoside compounds. 1995

R S Fletcher, and D Arion, and G Borkow, and M A Wainberg, and G I Dmitrienko, and M A Parniak
Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Quebec, Canada.

The carboxanilides UC84 and UC38 are nonnucleoside inhibitors of both the RNA-dependent and DNA-dependent DNA polymerase activities of HIV-1 reverse transcriptase (RT). We have previously shown that UC84 and UC38 bind to the same site as nevirapine but interact with different RT mechanistic forms, with UC84 preferentially binding to the RT-primer/template complex and UC38 binding only to the RT-primer/template-dNTP ternary complex [Fletcher, R. S., et al. (1995) Biochemistry 34, 4346-4353]. Here we demonstrate that combinations of UC84 and UC38 inhibit RT DNA polymerase activity in vitro in a synergistic manner. This synergy was noted primarily in reactions containing high concentrations of primer/template and Km levels of dNTP substrate and was independent of both primer/template identity and the molar ratio of UC84:UC38. Combination indices were in the range of 0.4-0.6, indicating substantial synergy in the inhibition of RT activity. More importantly, combinations of UC84 and UC38 also showed a high degree of synergy in inhibiting HIV-1 replication in both MT-4 and cord blood mononuclear cells. We believe this to be the first example of synergistic inhibition of HIV-1 RT by combinations of structurally related nonnucleoside inhibitors.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D002261 Carboxin A systemic agricultural fungicide and seed treatment agent. 5,6-Dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide,D-735,Vitavax,D 735,D735
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D001565 Benzoates Derivatives of BENZOIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxybenzene structure. Benzoate,Benzoic Acids,Acids, Benzoic
D013698 Templates, Genetic Macromolecular molds for the synthesis of complementary macromolecules, as in DNA REPLICATION; GENETIC TRANSCRIPTION of DNA to RNA, and GENETIC TRANSLATION of RNA into POLYPEPTIDES. Genetic Template,Genetic Templates,Template, Genetic
D013859 Thiocarbamates Carbamates in which the -CO- group has been replaced by a -CS- group. Thiocarbamate

Related Publications

R S Fletcher, and D Arion, and G Borkow, and M A Wainberg, and G I Dmitrienko, and M A Parniak
Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor.
December 1990, Science (New York, N.Y.),
R S Fletcher, and D Arion, and G Borkow, and M A Wainberg, and G I Dmitrienko, and M A Parniak
Synergistic inhibition of HIV-1 reverse transcriptase by combinations of chain-terminating nucleotides.
October 1997, Biochemistry,
R S Fletcher, and D Arion, and G Borkow, and M A Wainberg, and G I Dmitrienko, and M A Parniak
Mechanism of inhibition of HIV-1 reverse transcriptase by nonnucleoside inhibitors.
February 1995, Science (New York, N.Y.),
R S Fletcher, and D Arion, and G Borkow, and M A Wainberg, and G I Dmitrienko, and M A Parniak
Models which explain the inhibition of reverse transcriptase by HIV-1-specific (thio)carboxanilide derivatives.
May 1997, Biochemical and biophysical research communications,
R S Fletcher, and D Arion, and G Borkow, and M A Wainberg, and G I Dmitrienko, and M A Parniak
Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.
October 2004, Current HIV research,
R S Fletcher, and D Arion, and G Borkow, and M A Wainberg, and G I Dmitrienko, and M A Parniak
Efavirenz is a potent nonnucleoside reverse transcriptase inhibitor of HIV type 1 replication in microglia in vitro.
October 2000, AIDS research and human retroviruses,
R S Fletcher, and D Arion, and G Borkow, and M A Wainberg, and G I Dmitrienko, and M A Parniak
Inhibitors of HIV-1 reverse transcriptase and fidelity of in vitro DNA replication.
January 1992, Journal of enzyme inhibition,
R S Fletcher, and D Arion, and G Borkow, and M A Wainberg, and G I Dmitrienko, and M A Parniak
HIV-1 reverse transcriptase resistance to nonnucleoside inhibitors.
January 1996, Biochemistry,
R S Fletcher, and D Arion, and G Borkow, and M A Wainberg, and G I Dmitrienko, and M A Parniak
Nonnucleoside Reverse Transcriptase Inhibitor Hypersusceptibility and Resistance by Mutation of Residue 181 in HIV-1 Reverse Transcriptase.
August 2019, Antimicrobial agents and chemotherapy,
R S Fletcher, and D Arion, and G Borkow, and M A Wainberg, and G I Dmitrienko, and M A Parniak
Inhibition of HIV-1 reverse transcriptase and HIV-1 replication by Calophyllum coumarins and xanthones.
January 2002, Planta medica,
Copied contents to your clipboard!